Atopic_JJ Dermatitis_NP and_CC Fungi_NP Atopic_JJ dermatitis_NN (_( AD_NN )_) is_VBZ a_DT chronic_NN ,_, itching_VBG ,_, inflammatory_JJ skin_NN disease_NN which_WDT is_VBZ associated_VBN with_IN asthma_NN and/or_CC hay_NN fever_NN and_CC a_DT familial_JJ occurrence_NN of_IN these_DT conditions_NNS ._SENT Genetic_JJ factors_NNS are_VBP important_JJ in_IN the_DT development_NN of_IN AD_NN ,_, but_CC the_DT exact_JJ hereditary_JJ pathway_NN is_VBZ still_RB unknown_JJ ._SENT Dry_JJ skin_NN and_CC the_DT weakened_JJ barrier_NN function_NN in_IN patients_NNS with_IN AD_NN is_VBZ very_RB important_JJ for_IN the_DT patient_NN 's_POS reactions_NNS to_TO irritants_NNS and_CC other_JJ external_JJ trigger_NN factors_NNS including_VBG microorganisms_NNS ._SENT The_DT standard_JJ treatments_NNS are_VBP topical_JJ corticosteroids_NNS ,_, topical_JJ immunomodulating_JJ agents_NNS ,_, and_CC emollients_NNS ._SENT If_IN AD_NN cannot_MD be_VB controlled_VBN by_IN this_DT type_NN of_IN treatment_NN ,_, systemic_JJ immunomodulating_JJ agents_NNS may_MD be_VB used_VBN ._SENT UVB_NP ,_, UVA_NP ,_, or_CC psoralen-UVA_NP may_MD also_RB be_VB used_VBN for_IN widespread_JJ severe_JJ lesions_NNS ._SENT However_RB ,_, some_DT patients_NNS do_VBP not_RB respond_VB to_TO these_DT standard_JJ treatment_NN ,_, and_CC then_RB it_PP is_VBZ important_JJ to_TO consider_VB the_DT role_NN of_IN microorganisms_NNS ,_, house_NN dust_NN mites_NNS or_CC food_NN ._SENT The_DT role_NN of_IN the_DT Malassezia_NP yeasts_NNS in_IN AD_NN ,_, especially_RB AD_NNS located_VBN to_TO the_DT head_NN and_CC neck_NN region_NN ,_, is_VBZ now_RB documented_VBN in_IN several_JJ papers_NNS ._SENT There_EX are_VBP also_RB several_JJ papers_NNS indicating_VBG the_DT role_NN of_IN Candida_NP as_IN an_DT aggravating_JJ factor_NN in_IN AD_NP ._SENT Patients_NNS with_IN AD_NNS also_RB develop_VBP chronic_JJ dermatophyte_NN infections_NNS more_RBR easily_RB ,_, and_CC patients_NNS with_IN AD_JJ and_CC chronic_JJ dermatophyte_NN infections_NNS may_MD show_VB improvement_NN in_IN their_PP$ AD_NN when_WRB treated_VBN with_IN antifungal_JJ drugs_NNS ._SENT Atopic_JJ dermatitis_NN (_( AD_NN )_) is_VBZ a_DT chronic_NN ,_, itching_VBG ,_, inflammatory_JJ skin_NN disease_NN which_WDT is_VBZ associated_VBN with_IN asthma_NN and/or_CC hay_NN fever_NN and_CC a_DT familial_JJ occurrence_NN of_IN these_DT conditions_NNS ._SENT AD_NN is_VBZ the_DT most_RBS common_JJ chronic_JJ skin_NN disease_NN in_IN children_NNS ._SENT Approximately_RB 18_CD %_NN of_IN 7-year-old_JJ children_NNS have_VBP or_CC have_VBP had_VBN AD_NN ._SENT In_IN 90_CD %_NN of_IN patients_NNS the_DT disease_NN starts_VBZ before_IN 7_CD years_NNS of_IN age_NN ,_, and_CC usually_RB it_PP starts_VBZ before_RB 1_CD year_NN of_IN age_NN ._SENT The_DT majority_NN of_IN the_DT patients_NNS improve_VBP before_IN or_CC around_IN puberty_NN ,_, and_CC it_PP is_VBZ estimated_VBN that_IN approximately_RB 2_CD %_NN of_IN the_DT adult_NN population_NN has_VBZ AD_JJ ._SENT However_RB ,_, AD_NNS may_MD start_VB in_IN adult_NN life_NN ,_, although_IN this_DT is_VBZ rare_JJ ._SENT There_EX is_VBZ a_DT documented_VBN increase_NN in_IN the_DT incidence_NN of_IN AD_NN in_IN all_DT countries_NNS with_IN an_DT Western_JJ life-style_NN ,_, but_CC the_DT exact_JJ reason_NN for_IN this_DT is_VBZ unclear_JJ (_( the_DT frequency_NN of_IN AD_NNS in_IN 7-year-old_JJ children_NNS is_VBZ 2_CD to_TO 3_CD %_NN for_IN those_DT born_VBN before_IN 1960_CD ,_, 4_CD to_TO 8_CD %_NN for_IN those_DT born_VBN between_IN 1960_CD and_CC 1970_CD ,_, 9_CD to_TO 12_CD %_NN for_IN those_DT born_VBN between_IN 1970_CD and_CC 1980_CD ,_, and_CC 15_CD to_TO 20_CD %_NN for_IN those_DT born_VBN after_IN 1980_CD )_) ._SENT Genetic_JJ factors_NNS are_VBP important_JJ in_IN the_DT development_NN of_IN AD_NN ,_, but_CC the_DT exact_JJ hereditary_JJ pathway_NN is_VBZ still_RB unknown_JJ ._SENT If_IN both_DT parents_NNS have_VBP had_VBN AD_NN ,_, the_DT risk_NN for_IN the_DT children_NNS is_VBZ approximately_RB 70_CD %_NN ._SENT Infiltrates_NNS of_IN activated_VBN T-helper_NN cells_NNS are_VBP found_VBN in_IN the_DT skin_NN of_IN patients_NNS with_IN AD_NP ._SENT There_EX is_VBZ an_DT imbalance_NN between_IN Th1_NP and_CC Th2_NP cells_NNS toward_IN an_DT increase_NN in_IN cells_NNS of_IN the_DT Th2_NP type_NN ._SENT Th2_JJ cells_NNS have_VBP a_DT cytokine_NN profile_NN with_IN an_DT increased_VBN production_NN of_IN interleukin_NN 4_CD (_( IL-4_NN )_) ,_, which_WDT stimulates_VBZ the_DT plasma_NN cells_NNS to_TO an_DT increased_VBN production_NN of_IN immunoglobulin_NN E_NP (_( IgE_NP )_) ._SENT Another_DT interesting_JJ observation_NN in_IN the_DT skin_NN of_IN AD_JJ patients_NNS is_VBZ the_DT presence_NN of_IN a_DT dendritic_JJ epidermal_JJ cell_NN population_NN (_( Langerhans_NP '_POS cells_NNS and_CC mast_NN cells_NNS )_) that_WDT carry_VBP IgE_JJ receptors_NNS and_CC specific_JJ IgE_NNS ._SENT Antigen_NN presented_VBD by_IN these_DT cells_NNS may_MD stimulate_VB Th2_JJ cells_NNS to_TO synthesize_VB IgE_NP and_CC hence_RB contribute_VB to_TO the_DT inflammatory_JJ changes_NNS in_IN the_DT skin_NN ._SENT When_WRB the_DT skin_NN of_IN patients_NNS with_IN AD_NN is_VBZ examined_VBN ,_, it_PP is_VBZ often_RB drier_JJR than_IN the_DT skin_NN of_IN an_DT individual_NN without_IN AD_NP ._SENT It_PP also_RB reacts_VBZ differently_RB in_IN response_NN to_TO stimulation_NN ._SENT The_DT white_JJ dermography_NN appears_VBZ when_WRB the_DT skin_NN is_VBZ lightly_RB scratched_VBN and_CC is_VBZ characterized_VBN by_IN blood_NN vessel_NN constriction_NN instead_RB of_IN dilation_NN ._SENT The_DT threshold_NN for_IN itch_NN is_VBZ also_RB lower_JJR than_IN in_IN healthy_JJ individuals_NNS ._SENT Dry_JJ skin_NN and_CC the_DT weakened_JJ barrier_NN function_NN in_IN patients_NNS with_IN AD_NNS are_VBP very_RB important_JJ in_IN the_DT reactions_NNS of_IN the_DT patients_NNS to_TO irritants_NNS and_CC other_JJ external_JJ trigger_NN factors_NNS including_VBG microorganisms_NNS ._SENT The_DT pathophysiology_NN and_CC etiology_NN of_IN AD_NP have_VBP been_VBN reviewed_VBN and_CC discussed_VBN in_IN a_DT supplement_NN of_IN the_DT American_NP Journal_NP of_IN Dermatology_NP ._SENT Staphylococcus_NN aureus_NN can_MD be_VB cultured_VBN from_IN both_DT involved_JJ and_CC uninvolved_JJ skin_NN in_IN 85_CD to_TO 90_CD %_NN of_IN patients_NNS with_IN AD_NP ._SENT S._NP aureus_NN may_MD aggravate_VB AD_NNS due_JJ to_TO a_DT secondary_JJ infection_NN ._SENT However_RB ,_, of_IN greater_JJR importance_NN is_VBZ probably_RB the_DT presence_NN of_IN exotoxins_NNS and_CC other_JJ substances_NNS from_IN S._NP aureus_NN that_WDT may_MD act_VB as_IN allergens_NNS or_CC ,_, more_RBR importantly_RB ,_, as_IN superantigens_NNS ._SENT Viral_JJ infections_NNS ,_, especially_RB with_IN herpes_NN simplex_JJ virus_NN ,_, may_MD also_RB aggravate_VB AD_NNS ._SENT The_DT yeasts_NNS Malassezia_NP and_CC Candida_NP may_MD aggravate_VB AD_NNS due_JJ to_TO an_DT allergic_JJ reaction_NN ._SENT In_IN particular_JJ ,_, the_DT role_NN of_IN the_DT Malassezia_NP yeasts_NNS is_VBZ now_RB documented_VBN in_IN several_JJ papers_NNS ._SENT Malassezia_NN species_NNS are_VBP members_NNS of_IN the_DT normal_JJ human_JJ cutaneous_JJ flora_NN ,_, and_CC a_DT defect_NN in_IN the_DT skin_NN barrier_NN may_MD facilitate_VB the_DT contact_NN of_IN these_DT yeasts_NNS with_IN the_DT immune_JJ system_NN ._SENT Candida_NP yeasts_NNS are_VBP members_NNS of_IN the_DT normal_JJ flora_NN of_IN mucous_JJ membranes_NNS ,_, and_CC the_DT major_JJ contact_NN with_IN the_DT immune_JJ system_NN is_VBZ through_IN the_DT gastrointestinal_JJ tract_NN and_CC ,_, in_IN women_NNS ,_, even_RB through_IN the_DT vagina_NN ._SENT Chronic_JJ dermatophyte_NN infections_NNS are_VBP more_RBR common_JJ in_IN patients_NNS with_IN AD_NN ,_, and_CC dermatophytes_NNS ,_, especially_RB Trichophyton_NP rubrum_NN ,_, may_MD act_VB as_IN allergens_NNS ._SENT The_DT role_NN of_IN other_JJ hyphomycetes_NNS in_IN AD_NP has_VBZ not_RB been_VBN studied_VBN in_IN detail_NN ._SENT Other_JJ important_JJ factors_NNS are_VBP food_NN ,_, house_NN dust_NN mites_NNS ,_, topically_RB applied_VBN irritants_NNS ,_, psychological_JJ factors_NNS ,_, and_CC climate_NN ._SENT The_DT diagnosis_NN of_IN AD_NN is_VBZ usually_RB based_VBN on_IN many_JJ variables_NNS ,_, including_VBG history_NN and_CC clinical_JJ and_CC laboratory_NN findings_NNS ._SENT Rajka_NP was_VBD the_DT first_JJ to_TO make_VB a_DT diagnostic_JJ list_NN consisting_VBG of_IN major_JJ and_CC minor_JJ criteria_NNS ._SENT These_DT criteria_NNS were_VBD later_RBR revised_VBN and_CC are_VBP known_VBN as_IN the_DT Hanifin_NP and_CC Rajka_NP criteria_NNS ._SENT These_DT criteria_NNS have_VBP been_VBN scientifically_RB evaluated_VBN and_CC found_VBN to_TO work_VB fairly_RB well_RB in_IN the_DT clinical_JJ situation_NN even_RB though_RB many_JJ of_IN the_DT criteria_NNS have_VBP no_DT precise_JJ definition_NN ,_, some_DT are_VBP nonspecific_JJ ,_, and_CC some_DT are_VBP uncommon_JJ ._SENT However_RB ,_, Williams_NP et_FW al._FW developed_VBD a_DT minimum_JJ list_NN of_IN reliable_JJ criteria_NNS for_IN the_DT diagnosis_NN of_IN AD_NNS that_WDT could_MD be_VB used_VBN in_IN clinical_JJ as_IN well_RB as_RB in_IN epidemiological_JJ studies_NNS ._SENT The_DT obligatory_JJ criteria_NNS are_VBP an_DT itching_VBG skin_NN condition_NN or_CC report_NN from_IN parents_NNS that_IN a_DT young_JJ child_NN itches_NNS or_CC scratches_NNS as_RB if_IN itching_VBG ._SENT Thereafter_RB ,_, at_IN least_JJS three_CD of_IN the_DT following_VBG criteria_NNS should_MD be_VB fulfilled_VBN :_: history_NN of_IN involvement_NN of_IN the_DT skin_NN folds_VBZ on_IN the_DT flexor_NN sides_NNS of_IN the_DT elbows_NNS and_CC knees_NNS ,_, anteriorly_RB on_IN the_DT ankles_NNS ,_, on_IN the_DT throat_NN ,_, and_CC on_IN the_DT cheeks_NNS in_IN children_NNS younger_JJR than_IN 10_CD years_NNS ;_: history_NN of_IN asthma_NN or_CC hay_NN fever_NN in_IN the_DT patient_NN or_CC of_IN atopic_JJ disease_NN in_IN the_DT immediate_JJ family_NN of_IN children_NNS younger_JJR than_IN 4_CD years_NNS ;_: history_NN of_IN general_JJ skin_NN dryness_NN during_IN the_DT last_JJ year_NN ;_: visible_JJ eczema_NN present_NN on_IN the_DT flexor_NN sides_NNS of_IN the_DT elbows_NNS and_CC knees_NNS ,_, anteriorly_RB on_IN the_DT ankles_NNS ,_, and_CC on_IN the_DT throat_NN (_( or_CC cheeks_NNS ,_, forehead_NN ,_, and_CC extensor_NN side_NN of_IN the_DT extremities_NNS in_IN children_NNS younger_JJR than_IN 4_CD years_NNS )_) ;_: and_CC onset_NN before_IN the_DT age_NN of_IN 2_CD years_NNS (_( this_DT criterion_NN should_MD not_RB be_VB used_VBN if_IN the_DT child_NN is_VBZ younger_JJR than_IN 4_CD years_NNS )_) ._SENT The_DT clinical_JJ picture_NN varies_VBZ with_IN age_NN and_CC may_MD be_VB described_VBN in_IN 3_CD different_JJ phases_NNS :_: infant_JJ phase_NN (_( younger_JJR than_IN 2_CD years_NNS )_) ,_, childhood_NN phase_NN (_( 2_CD to_TO 12_CD years_NNS )_) ,_, and_CC adolescent/adult_NN phase_NN ._SENT Important_JJ differential_JJ diagnoses_NNS are_VBP seborrheic_JJ dermatitis_NN ,_, psoriasis_NN ,_, rosacea_NN and_CC perioral_JJ dermatitis_NN ,_, fungal_JJ infections_NNS ,_, ichtyosis_NN vulgaris_NNS ,_, scabies_NN and_CC contact_NN dermatitis_NN ._SENT Accurate_JJ assessment_NN of_IN the_DT extent_NN and_CC severity_NN of_IN AD_NN is_VBZ essential_JJ for_IN quantitating_VBG the_DT baseline_JJ clinical_JJ disease_NN burden_NN and_CC the_DT effectiveness_NN of_IN treatment_NN regimens_NNS being_VBG tested_VBN ._SENT One_CD assessment_NN system_NN that_WDT is_VBZ videly_RB used_VBN is_VBZ the_DT SCORAD_NP method_NN ,_, and_CC another_DT method_NN is_VBZ the_DT EASI_NP ._SENT It_PP is_VBZ beyond_IN the_DT scope_NN of_IN this_DT article_NN to_TO discuss_VB which_WDT one_CD may_MD be_VB superior_JJ ._SENT Treatment_NN of_IN AD_NN is_VBZ topical_JJ with_IN emollients_NNS ,_, corticosteroids_NNS ,_, or_CC immunomodulating_VBG agents_NNS ._SENT The_DT use_NN of_IN topical_JJ tacrolimus_NN is_VBZ a_DT new_JJ approach_NN to_TO the_DT treatment_NN of_IN AD_NP ._SENT In_IN severe_JJ AD_NNS ,_, systemic_JJ treatment_NN with_IN corticosteroids_NNS and_CC immunomodulating_VBG drugs_NNS is_VBZ needed_VBN ._SENT UV_NP treatment_NN is_VBZ also_RB an_DT effective_JJ alternative_NN ._SENT Topical_JJ and_CC systemic_JJ antibacterial_NN treatment_NN is_VBZ used_VBN in_IN patients_NNS with_IN signs_NNS of_IN bacterial_JJ infections_NNS ._SENT Antifungal_JJ therapy_NN is_VBZ used_VBN in_IN patients_NNS with_IN signs_NNS of_IN a_DT fungal_JJ infection_NN ._SENT However_RB ,_, a_DT more_RBR widespread_JJ use_NN of_IN antimycotics_NNS based_VBN on_IN the_DT role_NN of_IN the_DT most_JJS yeasts_NNS as_IN common_JJ allergens_NNS is_VBZ still_RB not_RB commonly_RB recommended_VBN ._SENT The_DT prognosis_NN of_IN AD_NN is_VBZ good_JJ ;_: 60_CD to_TO 70_CD %_NN of_IN patients_NNS recover_VBP during_IN childhood_NN ._SENT The_DT prognosis_NN is_VBZ less_RBR positive_JJ in_IN women_NNS ,_, in_IN patients_NNS who_WP had_VBD severe_JJ AD_NN as_IN children_NNS ,_, and_CC in_IN those_DT with_IN concurrent_JJ allergic_JJ rhinitis_NN and/or_CC asthma_NN or_CC a_DT positive_JJ family_NN history_NN of_IN AD_NP ._SENT Not_RB only_JJ bacteria_NNS ,_, especially_RB S._NP aureus_NN ,_, but_CC also_RB fungi_NNS may_MD play_VB an_DT important_JJ role_NN as_IN aggravating_JJ factors_NNS in_IN AD_NP ._SENT The_DT majority_NN of_IN studies_NNS in_IN AD_NNS and_CC fungi_NNS deal_NN with_IN the_DT Malassezia_NP yeasts_NNS ,_, probably_RB because_IN these_DT yeasts_NNS are_VBP the_DT most_RBS important_JJ fungi_NNS in_IN AD_NP ._SENT Historical_JJ ._SENT |_SYM The_DT earliest_JJS report_NN of_IN Malassezia-like_JJ yeasts_NNS was_VBD made_VBN by_IN Eichstedt_NP in_IN 1846_CD ._SENT In_IN 1853_CD ,_, Robin_NP described_VBD round_NN cells_NNS on_IN the_DT skin_NN of_IN patients_NNS with_IN dandruff_NN ._SENT In_IN 1873_CD ,_, Rivolta_NP described_VBD the_DT presence_NN of_IN round_JJ double-contoured_JJ budding_JJ cells_NNS in_IN a_DT patient_NN with_IN psoriasis_NN ._SENT In_IN 1874_CD ,_, Malassez_NP noticed_VBD budding_VBG cells_NNS of_IN various_JJ shapes_NNS in_IN the_DT stratum_NN corneum_NN of_IN patients_NNS with_IN various_JJ skin_NN diseases_NNS ,_, and_CC the_DT name_NN Malassezia_NP furfur_NN was_VBD proposed_VBN by_IN Bailon_NP in_IN 1889_CD ._SENT However_RB ,_, Malassez_NP was_VBD never_RB able_JJ to_TO culture_VB the_DT microorganism_NN ._SENT Von_NP Sehlen_NP and_CC Unna_NP were_VBD probably_RB the_DT first_JJ to_TO culture_VB the_DT organism_NN ._SENT The_DT genus_NN name_NN Pityrosporum_NP was_VBD proposed_VBN by_IN Sabouraud_NP in_IN 1904_CD ._SENT In_IN 1913_CD ,_, Castellani_NP and_CC Chalmers_NP were_VBD able_JJ to_TO culture_VB the_DT organism_NN and_CC characterize_VB the_DT growth_NN properties_NNS ._SENT They_PP introduced_VBD the_DT name_NN Pityrosporum_NP ovale_NP ,_, and_CC their_PP$ description_NN of_IN the_DT organism_NN is_VBZ based_VBN on_IN the_DT characteristics_NNS of_IN the_DT fungus_NN both_CC in_IN skin_NN scales_NNS and_CC in_IN the_DT laboratory_NN ._SENT The_DT name_NN P._NP pachydermatis_NN was_VBD introduced_VBN by_IN Veidman_NP in_IN 1925_CD for_IN a_DT nonlipophilic_JJ species_NN of_IN the_DT genus_NN Pityrosporum_NN isolated_VBN primarily_RB from_IN animals_NNS ._SENT In_IN 1951_CD ,_, Gordon_NP isolated_VBD a_DT round_NN ,_, double-contoured_JJ yeast_NN that_WDT produced_VBD spherical_JJ to_TO oval_JJ buds_NNS from_IN both_DT pityriasis_NN versicolor_JJ scales_NNS and_CC normal_JJ skin_NN ._SENT The_DT name_NN he_PP gave_VBD the_DT organism_NN ,_, P._NP orbicualre_NP ,_, is_VBZ based_VBN primarily_RB on_IN the_DT micromorphology_NN ._SENT However_RB ,_, later_JJR studies_NNS have_VBP shown_VBN that_IN the_DT round_NN and_CC oval_JJ forms_NNS of_IN the_DT organism_NN are_VBP not_RB stable_JJ and_CC that_IN the_DT two_CD forms_NNS can_MD change_VB from_IN one_CD to_TO the_DT other_JJ on_IN special_JJ culture_NN media_NNS or_CC under_IN special_JJ culture_NN conditions_NNS and_CC when_WRB experimental_JJ infections_NNS are_VBP induced_VBN in_IN rabbits_NNS ._SENT The_DT genus_NN Malassezia_NP has_VBZ in_IN a_DT taxonomic_JJ revision_NN been_VBN placed_VBN in_IN the_DT kingdom_NN Fungi_NP ,_, division_NN Basidiomycota_NP ,_, class_NN Hymenomycetes_NNS ,_, order_NN Tremellales_NNS and_CC family_NN Filobasidium_NN uniguttulatum_NN ._SENT Molecular_JJ biology_NN using_VBG rRNA_NN sequence_NN analysis_NN and_CC nDNA_NN comparisons_NNS ,_, as_RB well_RB as_IN G+C_NP content_NN in_IN extracted_VBN DNA_NN ,_, has_VBZ clearly_RB divided_VBN the_DT genus_NN Malassezia_NN into_IN seven_CD different_JJ species_NNS ._SENT Today_NN this_DT genus_NN consists_VBZ of_IN M._NP furfur_NN ,_, M._NP pachydermatis_NP ,_, M._NP sympodialis_NP ,_, M._NP globosa_NP ,_, M._NP slooffiae_NNS ,_, M._NP restricta_NP ,_, and_CC M._NP obtusa_NP ._SENT The_DT seven_CD Malassezia_NP species_NNS exhibit_VBP typical_JJ morphological_JJ and_CC physiological_JJ features_NNS ._SENT They_PP reproduce_VBP by_IN unilateral_JJ budding_VBG ,_, leaving_VBG prominent_JJ scars_NNS on_IN the_DT mother_NN cells_NNS ._SENT The_DT yeast_NN cells_NNS may_MD be_VB bottle-shaped_JJ ,_, globose_JJ ,_, ovoid_JJ ,_, or_CC cylindrical_JJ ._SENT Buds_NNS may_MD be_VB formed_VBN on_IN a_DT narrow_JJ or_CC wide_JJ base_NN ._SENT The_DT most_RBS interesting_JJ feature_NN of_IN the_DT genus_NN Malassezia_NP is_VBZ the_DT presence_NN of_IN a_DT thick_JJ multilayered_VBN cell_NN wall_NN whose_WP$ inner_JJ surface_NN is_VBZ corrugated_VBN ._SENT The_DT protoplasmic_JJ membrane_NN is_VBZ firmly_RB attached_VBN to_TO the_DT inside_NN of_IN the_DT cell_NN wall_NN ._SENT The_DT major_JJ components_NNS of_IN the_DT cell_NN wall_NN are_VBP mannoproteins_NNS (_( 75_CD to_TO 80_CD %_NN )_) ,_, lipids_NNS (_( 15_CD to_TO 20_CD %_NN )_) ,_, and_CC chitin_NN (_( 1_CD to_TO 2_CD %_NN )_) ._SENT It_PP is_VBZ thought_VBN that_IN the_DT immunomodulatory_JJ capacity_NN of_IN the_DT Malassezia_NP yeasts_NNS are_VBP related_VBN to_TO cell_NN wall_NN lipids_NNS ._SENT Using_VBG various_JJ physical_NN ,_, chemical_NN and_CC metabolic_JJ characteristics_NNS ,_, the_DT Malassezia_NP species_NN can_MD be_VB identified_VBN ._SENT We_PP have_VBP recently_RB developed_VBN a_DT modification_NN of_IN previous_JJ identification_NN systems_NNS by_IN which_WDT the_DT seven_CD different_JJ Malassezia_NP species_NNS easily_RB can_MD be_VB identified_VBN ._SENT The_DT advantages_NNS of_IN this_DT system_NN are_VBP that_IN it_PP is_VBZ easier_JJR and_CC faster_RBR and_CC that_DT Tween_NP reaction_NN ,_, which_WDT is_VBZ often_RB difficult_JJ to_TO read_VB ,_, is_VBZ not_RB necessary_JJ ._SENT We_PP always_RB isolate_VBP the_DT Malassezia_NP yeast_NN using_VBG the_DT media_NNS described_VBN by_IN Leeming_NP and_CC Notman_NP ._SENT This_DT medium_NN contains_VBZ ,_, among_IN other_JJ ingredients_NNS ,_, ox_NN bile_NN ,_, glycerol_NN ,_, glycerol_NN monostearate_NNS ,_, Tween_NP 60_CD ,_, and_CC whole-fat_JJ cow_NN 's_POS milk_NN ._SENT Compared_VBN to_TO other_JJ culture_NN media_NNS ,_, this_DT was_VBD the_DT most_RBS effective_JJ for_IN isolation_NN of_IN the_DT Malassezia_NP yeasts_NNS ._SENT Various_JJ morphological_JJ and_CC physiological_JJ criteria_NNS can_MD be_VB used_VBN to_TO characterize_VB the_DT Malassezia_NP yeasts_NNS ._SENT M._NP pachydermatis_NN is_VBZ nonlipophilic_JJ and_CC can_MD be_VB cultured_VBN on_IN lipid-free_JJ culture_NN media_NNS ._SENT Cells_NNS are_VBP small_JJ and_CC ovoid_JJ with_IN a_DT very_RB broad_JJ base_NN ,_, and_CC they_PP never_RB produce_VBP filaments_NNS ._SENT M._NP furfur_NN can_MD vary_VB in_IN micromorphology_NN ,_, producing_VBG cells_NNS that_WDT are_VBP long_RB cylindrical_JJ ovoid_NN or_CC even_RB globose_JJ ._SENT A_DT few_JJ strains_NNS may_MD produce_VB filaments_NNS spontaneously_RB or_CC during_IN special_JJ culture_NN conditions_NNS ._SENT M._NP furfur_NN is_VBZ catalase_NN positive_JJ ,_, does_VBZ not_RB split_VB esculin_NN ,_, grows_VBZ on_IN Dixon_NP agar_NN at_IN 38C_JJ ,_, and_CC is_VBZ capable_JJ of_IN growing_VBG in_IN the_DT presence_NN of_IN Cremophor_NP ._SENT M._NP sympodialis_NP has_VBZ small_JJ ovoid_JJ cells_NNS ._SENT It_PP is_VBZ catalase_NN positive_JJ ,_, splits_VBZ esculin_NN ,_, grows_VBZ on_IN Dixon_NP agar_NN at_IN 38C_JJ ,_, and_CC is_VBZ not_RB capable_JJ of_IN growing_VBG in_IN the_DT presence_NN of_IN Cremophor_NP ._SENT M._NP slooffiae_NNS has_VBZ short_JJ cylindrical_JJ cells_NNS appearing_VBG ovoid_NN under_IN the_DT light_JJ microscope_NN with_IN buds_NNS formed_VBN on_IN a_DT broad_JJ base_NN ._SENT It_PP is_VBZ catalase_NN positive_JJ ,_, does_VBZ not_RB split_VB esculin_NN ,_, grows_VBZ on_IN Dixon_NP agar_NN at_IN 38C_JJ ,_, and_CC is_VBZ not_RB capable_JJ of_IN growing_VBG in_IN the_DT presence_NN of_IN Cremophor_NP ._SENT M._NP obtusa_NP has_VBZ large_JJ cylindrical_JJ cells_NNS with_IN a_DT broad_JJ base_NN ._SENT It_PP is_VBZ catalase_NN positive_JJ ,_, splits_VBZ esculin_NN ,_, does_VBZ not_RB grow_VB on_IN Dixon_NP agar_NN at_IN 38C_JJ ,_, and_CC is_VBZ not_RB capable_JJ of_IN growing_VBG in_IN the_DT presence_NN of_IN Cremophor_NP ._SENT M._NP globosa_NP has_VBZ stable_JJ spherical_JJ cells_NNS ._SENT Buds_NNS are_VBP formed_VBN on_IN a_DT narrow_JJ base_NN and_CC might_MD elongate_VB to_TO form_VB germination_NN tubes_NNS or_CC even_RB short_JJ filaments_NNS ._SENT It_PP is_VBZ catalase_NN positive_JJ ,_, does_VBZ not_RB split_VB esculin_NN ,_, does_VBZ not_RB grow_VB on_IN Dixon_NP agar_NN at_IN 38C_JJ ,_, and_CC is_VBZ not_RB capable_JJ of_IN growing_VBG in_IN the_DT presence_NN of_IN Cremophor_NP ._SENT M._NP restricta_NP has_VBZ small_JJ spherical_JJ or_CC ovoid_JJ cells_NNS with_IN a_DT relatively_RB narrow_JJ base_NN ._SENT It_PP is_VBZ catalase_NN negative_JJ ,_, does_VBZ not_RB split_VB esculin_NN ,_, does_VBZ not_RB grow_VB on_IN Dixon_NP agar_NN at_IN 38C_JJ ,_, and_CC is_VBZ not_RB capable_JJ of_IN growing_VBG in_IN the_DT presence_NN of_IN Cremophor_NP ._SENT FIG._NN 1_CD ._SENT |_SYM Typing_NP system_NN for_IN the_DT Malassezia_NP yeasts_NNS ._SENT Typing_VBG system_NN for_IN the_DT Malassezia_NP yeasts_NNS ._SENT The_DT Malassezia_NP yeasts_NNS are_VBP members_NNS of_IN the_DT normal_JJ human_JJ cutaneous_JJ flora_NN ._SENT However_RB ,_, there_EX is_VBZ great_JJ variation_NN in_IN the_DT density_NN and_CC presence_NN in_IN various_JJ skin_NN locations_NNS ,_, in_IN children_NNS compared_VBN to_TO adults_NNS ,_, and_CC in_IN normal_JJ skin_NN compared_VBN to_TO diseased_JJ skin_NN ._SENT The_DT Malassezia_NP yeasts_NNS are_VBP also_RB associated_VBN with_IN several_JJ skin_NN diseases_NNS such_JJ as_IN pityriasis_NN (_( tinea_NN )_) versicolor_JJ ,_, Malassezia_NP folliculitis_NP ,_, seborrheic_JJ dermatitis_NN ,_, atopic_JJ dermatitis_NN ,_, and_CC some_DT forms_NNS of_IN confluent_JJ and_CC reticulate_JJ papillomatosis_NN (_( Gougerot-Carteaud_NP syndrome_NN )_) ._SENT They_PP may_MD even_RB be_VB involved_VBN in_IN systemic_JJ diseases_NNS ._SENT In_IN 1951_CD ,_, Gordon_NP isolated_VBD lipophilic_JJ yeasts_NNS from_IN both_DT normal_JJ healthy_JJ volunteers_NNS and_CC patients_NNS with_IN pityriasis_NN versicolor_JJ ._SENT Using_VBG direct_JJ microscopy_NN or_CC culture_NN ,_, Roberts_NP found_VBN what_WP he_PP called_VBD P._NP ovale_NP on_IN the_DT scalp_NN and_CC on_IN the_DT chest_NN of_IN 97_CD %_NN and_CC 92_CD to_TO 100_CD %_NN normal_JJ healthy_JJ adults_NNS ,_, respectively_RB ._SENT He_PP also_RB isolated_VBD the_DT yeast_NN in_IN large_JJ numbers_NNS from_IN patients_NNS with_IN pityriasis_NN versicolor_JJ ._SENT In_IN a_DT quantitative_JJ culture_NN study_NN ,_, using_VBG a_DT modification_NN of_IN the_DT Williamson-Kligman_NP scrub_NN technique_NN ,_, Malassezia_NP yeasts_NNS were_VBD cultured_VBN from_IN clinically_RB normal_JJ skin_NN of_IN the_DT on_IN the_DT chest_NN ,_, back_RB ,_, upper_JJ arm_NN ,_, lower_JJR leg_NN ,_, and_CC dorsal_JJ aspect_NN of_IN the_DT hand_NN ._SENT The_DT highest_JJS count_NN was_VBD found_VBN on_IN the_DT back_NN ,_, and_CC the_DT lowest_JJS was_VBD found_VBN on_IN the_DT hand_NN ._SENT An_DT easy_JJ semiquantitative_JJ method_NN is_VBZ to_TO use_VB contact_NN plates_NNS ._SENT This_DT was_VBD first_RB described_VBN in_IN detail_NN in_IN 1987_CD ._SENT However_RB ,_, better_JJR results_NNS have_VBP later_RBR been_VBN obtained_VBN using_VBG a_DT modification_NN of_IN the_DT culture_NN medium_NN developed_VBN by_IN Leeming_NP and_CC Notman_NP ._SENT Leeming_NP et_FW al._FW were_VBD able_JJ to_TO culture_VB the_DT Malassezia_NP yeasts_NNS from_IN 20_CD different_JJ body_NN sites_NNS ,_, with_IN the_DT largest_JJS numbers_NNS being_VBG found_VBN on_IN the_DT scalp_NN and_CC upper_JJ trunk_NN ._SENT We_PP found_VBD in_IN a_DT culture_NN study_NN of_IN adults_NNS that_IN the_DT density_NN of_IN the_DT Malassezia_NP yeasts_NNS decreased_VBD with_IN increasing_VBG age_NN ._SENT Although_IN the_DT number_NN of_IN yeast_NN cells_NNS is_VBZ larger_JJR in_IN adults_NNS ,_, the_DT yeasts_NNS can_MD also_RB be_VB cultured_VBN from_IN children_NNS ._SENT Several_JJ studies_NNS have_VBP demonstrated_VBN that_IN the_DT Malassezia_NP yeasts_NNS can_MD be_VB cultured_VBN in_IN newborns_NNS ._SENT The_DT Malassezia_NP yeasts_NNS can_MD be_VB cultured_VBN not_RB only_RB from_IN healthy_JJ skin_NN but_CC also_RB from_IN patients_NNS with_IN various_JJ skin_NN diseases_NNS ._SENT The_DT number_NN of_IN yeasts_NNS is_VBZ not_RB always_RB increased_VBN ,_, but_CC other_JJ mechanisms_NNS may_MD be_VB important_JJ in_IN the_DT pathogenesis_NN ._SENT The_DT yeast_NN may_MD induce_VB immunological_JJ changes_NNS or_CC behave_VB as_IN irritants_NNS ,_, and_CC then_RB a_DT reduction_NN even_RB of_IN a_DT relatively_RB small_JJ number_NN of_IN yeast_NN cells_NNS will_MD result_VB in_IN an_DT improvement_NN ._SENT Quantitative_JJ or_CC semiquantitative_JJ cultures_NNS can_MD therefore_RB be_VB used_VBN to_TO monitor_VB the_DT effect_NN of_IN treatment_NN or_CC changes_NNS in_IN predisposing_VBG factors_NNS ._SENT Only_RB a_DT few_JJ culture_NN studies_NNS have_VBP been_VBN done_VBN using_VBG the_DT new_JJ classification_NN of_IN the_DT Malassezia_NP yeasts_NNS ._SENT However_RB ,_, it_PP is_VBZ important_JJ to_TO look_VB at_IN the_DT distribution_NN of_IN the_DT various_JJ Malassezia_NP species_NNS not_RB only_RB on_IN healthy_JJ skin_NN but_CC also_RB on_IN the_DT skin_NN of_IN patients_NNS with_IN Malassezia-associated_JJ skin_NN diseases_NNS ._SENT Nakabayashi_NP et_FW al._FW isolated_JJ various_JJ Malassezia_NP species_NNS from_IN the_DT skin_NN of_IN healthy_JJ individuals_NNS and_CC from_IN patients_NNS with_IN pityriasis_NN versicolor_JJ ,_, seborrheic_JJ dermatitis_NN ,_, and_CC atopic_JJ dermatitis_NN in_IN Japan_NP ._SENT The_DT yeasts_NNS were_VBD cultured_VBN qualitatively_RB using_VBG swabs_NNS and_CC Dixon_NP 's_POS agar_NN medium_NN ,_, and_CC specimens_NNS for_IN culture_NN were_VBD taken_VBN from_IN the_DT scalp_NN ,_, face_NN and_CC trunk_NN ._SENT Cultures_NNS were_VBD negative_JJ in_IN 14_CD %_NN (_( pityrasis_NN versicolor_JJ )_) to_TO 50_CD %_NN (_( healthy_JJ individuals_NNS )_) of_IN cases_NNS ._SENT M._NP globosa_NP was_VBD the_DT most_RBS commonly_RB isolated_VBN species_NNS from_IN healthy_JJ volunteers_NNS ,_, patients_NNS with_IN pityriasis_NN versicolor_JJ ,_, and_CC nonlesional_JJ skin_NN of_IN patients_NNS with_IN AD_NP ._SENT M._NP furfur_NN was_VBD the_DT most_RBS commonly_RB isolated_VBN species_NNS from_IN patients_NNS with_IN seborrheic_JJ dermatitis_NN and_CC lesional_JJ skin_NN of_IN patients_NNS with_IN AD_NN ._SENT In_IN a_DT study_NN by_IN Kim_NP and_CC Kim_NP ,_, the_DT Malassezia_NP yeasts_NNS were_VBD isolated_VBN qualitatively_RB from_IN various_JJ body_NN regions_NNS in_IN normal_JJ healthy_JJ volunteers_NNS from_IN South_NP Korea_NP ._SENT All_DT six_CD lipophilic_JJ species_NNS were_VBD cultured_VBN ._SENT However_RB ,_, there_EX was_VBD a_DT great_JJ variation_NN in_IN the_DT incidence_NN of_IN these_DT yeasts_NNS ,_, with_IN M._NP restricta_NP being_VBG the_DT most_RBS commonly_RB isolated_VBN species_NNS from_IN the_DT scalp_NN and_CC forehead_NN and_CC M._NP globosa_NP being_VBG the_DT most_RBS commonly_RB species_NNS isolated_VBN from_IN the_DT chest_NN and_CC the_DT back_NN ._SENT In_IN two_CD reports_NNS from_IN Canada_NP ,_, Gupta_NP et_FW al._FW have_VBP isolated_VBN the_DT various_JJ Malassezia_NP yeasts_NNS from_IN both_DT healthy_JJ individuals_NNS and_CC patients_NNS with_IN various_JJ Malassezia-related_JJ skin_NN diseases_NNS ._SENT In_IN the_DT first_JJ study_NN ,_, the_DT Malassezia_NP yeasts_NNS were_VBD isolated_VBN qualitatively_RB ,_, in_IN patients_NNS with_IN pityriasis_NN versicolor_JJ ,_, by_IN scraping_VBG skin_NN flakes_NNS into_IN a_DT paper_NN bag_NN ,_, and_CC later_RBR the_DT flakes_NNS were_VBD transferred_VBN to_TO Leeming_NP and_CC Notman_NP agar_NN and_CC to_TO Littman_NP agar_NN supplemented_VBN with_IN olive_JJ oil_NN ._SENT A_DT total_NN of_IN 111_CD samples_NNS were_VBD obtained_VBN from_IN patients_NNS in_IN Ontario_NP ,_, Canada_NP ,_, and_CC 18_CD were_VBD from_IN patients_NNS in_IN other_JJ countries_NNS (_( South_NP Africa_NP ,_, Hong_NP Kong_NP ,_, Portugal_NP ,_, Brazil_NP ,_, and_CC Hawaii_NP )_) ._SENT In_IN the_DT patients_NNS from_IN Canada_NP ,_, M._NP sympodialis_NNS was_VBD isolated_VBN in_IN 59_CD %_NN ,_, M._NP globosa_NP was_VBD isolated_VBN in_IN 25_CD %_NN ,_, and_CC M._NP furfur_NN was_VBD isolated_VBN in_IN 11_CD %_NN ._SENT In_IN patients_NNS from_IN other_JJ countries_NNS ,_, M._NP globosa_NP was_VBD the_DT dominating_JJ species_NNS ,_, being_VBG cultured_VBN in_IN 62_CD %_NN ._SENT In_IN the_DT other_JJ study_NN ,_, the_DT Malassezia_NP yeasts_NNS were_VBD isolated_VBN semiquantitatively_RB ,_, using_VBG contact_NN plates_NNS with_IN the_DT Leeming_NP and_CC Notman_NP agar_NN ,_, from_IN both_DT healthy_JJ volunteers_NNS and_CC patients_NNS with_IN pityriasis_NN versicolor_JJ ,_, seborrheic_JJ dermatitis_NN ,_, AD_NP ,_, and_CC psoriasis_NN ._SENT All_PDT the_DT lipophilic_JJ Malassezia_NP species_NNS were_VBD isolated_VBN ._SENT M._NP sympodialis_NP was_VBD the_DT dominant_JJ organism_NN in_IN healthy_JJ controls_NNS and_CC in_IN patients_NNS with_IN pityriasis_NN versicolor_JJ and_CC AD_JJ ,_, while_IN M._NP globosa_NP was_VBD the_DT dominant_JJ species_NN in_IN patients_NNS with_IN seborrheic_JJ dermatitis_NN and_CC psoriasis_NN ._SENT The_DT number_NN of_IN yeast_NN colonies_NNS was_VBD largest_JJS in_IN lesional_JJ skin_NN from_IN patients_NNS with_IN pityriasis_NN versicolor_JJ but_CC was_VBD not_RB statistically_RB significantly_RB larger_JJR than_IN in_IN nonlesional_JJ skin_NN or_CC in_IN skin_NN from_IN healthy_JJ individuals_NNS ._SENT However_RB ,_, the_DT number_NN of_IN colonies_NNS of_IN Malassezia_NP was_VBD statistically_RB significantly_RB larger_JJR in_IN both_DT healthy_JJ individuals_NNS and_CC patients_NNS with_IN pityriasis_NN versicolor_JJ than_IN in_IN patients_NNS with_IN seborrheic_JJ dermatitis_NN ,_, AD_NP ,_, and_CC psoriasis_NN ._SENT Erchiga_NP et_FW al_NP ,_, cultured_VBD the_DT various_JJ Malassezia_NP species_NNS qualitatively_RB using_VBG Dixon_NP agar_NN from_IN both_DT lesional_JJ and_CC nonlesional_JJ skin_NN of_IN patients_NNS with_IN pityriasis_NN versicolor_JJ in_IN Spain_NP ._SENT Cultures_NNS were_VBD positive_JJ in_IN all_DT patients_NNS ._SENT M._NP globosa_NP ,_, either_CC alone_RB or_CC in_IN combination_NN with_IN M._NP sympodialis_NP ,_, was_VBD the_DT dominant_JJ species_NNS ,_, being_VBG cultured_VBN in_IN 97_CD %_NN of_IN patients_NNS ;_: M._NP sympodialis_NP was_VBD cultured_VBN in_IN 32_CD %_NN ,_, either_CC together_RB with_IN M._NP globosa_NP or_CC alone_RB (_( only_RB three_CD patients_NNS )_) ._SENT In_IN nonlesional_JJ skin_NN from_IN the_DT shoulders_NNS ,_, Malassezia_NP species_NNS were_VBD cultured_VBN in_IN 47_CD %_NN of_IN the_DT patients_NNS and_CC M._NP sympodialis_NP was_VBD the_DT dominant_JJ species_NNS ,_, being_VBG cultured_VBN in_IN 42_CD %_NN of_IN all_DT cultures_NNS ._SENT According_VBG to_TO these_DT five_CD reports_NNS ,_, M._NP sympodialis_NP ,_, M._NP globosa_NP ,_, and_CC M._NP furfur_NN were_VBD the_DT most_RBS commonly_RB isolated_VBN Malassezia_NP species_NNS ._SENT However_RB ,_, there_EX were_VBD differences_NNS in_IN the_DT species_NN that_WDT was_VBD most_RBS commonly_RB isolated_VBN ,_, not_RB only_RB between_IN healthy_JJ individuals_NNS and_CC patients_NNS with_IN various_JJ diseases_NNS but_CC also_RB between_IN results_NNS from_IN different_JJ countries_NNS ._SENT As_RB mentioned_VBN above_RB ,_, the_DT Malassezia_NP yeasts_NNS are_VBP opportunistic_JJ pathogens_NNS ,_, and_CC under_IN the_DT influence_NN of_IN various_JJ predisposing_VBG factors_NNS ,_, they_PP are_VBP involved_VBN in_IN several_JJ diseases_NNS ._SENT In_IN pityriasis_NN versicolor_JJ ,_, under_IN the_DT influence_NN of_IN exogenous_JJ or_CC endogenous_JJ predisposing_VBG factors_NNS ,_, the_DT yeast_NN changes_NNS from_IN the_DT blastospore_NN form_NN to_TO the_DT mycelial_JJ form_NN ._SENT Pityriasis_NN versicolor_JJ is_VBZ a_DT chronic_JJ superficial_JJ disease_NN that_WDT usually_RB affects_VBZ the_DT upper_JJ trunk_NN ,_, neck_NN ,_, or_CC upper_JJ arms_NNS ._SENT It_PP has_VBZ a_DT worldwide_JJ distribution_NN ._SENT In_IN tropical_JJ areas_NNS ,_, it_PP has_VBZ been_VBN found_VBN in_IN 30_CD to_TO 40_CD %_NN of_IN the_DT population_NN ._SENT However_RB ,_, the_DT incidence_NN is_VBZ much_RB lower_JJR in_IN temperate_JJ climates_NNS ._SENT The_DT diagnosis_NN is_VBZ based_VBN primarily_RB on_IN a_DT typical_JJ clinical_JJ picture_NN in_IN combination_NN with_IN bright_JJ yellow_JJ fluorescence_NN under_IN Wood_NP 's_POS light_JJ examination_NN and_CC direct_JJ microscopy_NN ._SENT Direct_JJ microscopy_NN is_VBZ of_IN major_JJ importance_NN ,_, and_CC the_DT round_NN or_CC oval_JJ budding_VBG cells_NNS and_CC hyphae_NNS can_MD easily_RB be_VB identified_VBN ._SENT There_EX are_VBP numerous_JJ ways_NNS of_IN treating_VBG pityriasis_NN versicolor_JJ ,_, both_CC topically_RB and_CC with_IN systemic_JJ drugs_NNS ._SENT However_RB ,_, the_DT high_JJ rate_NN of_IN recurrence_NN ,_, affecting_VBG 60_CD %_NN of_IN patients_NNS after_IN 1_CD year_NN and_CC 80_CD %_NN after_IN 2_CD years_NNS ,_, is_VBZ an_DT outstanding_JJ problem_NN ._SENT Consequently_RB ,_, a_DT prophylactic_JJ treatment_NN regimen_NN is_VBZ necessary_JJ to_TO avoid_VB recurrence_NN ._SENT Malassezia_NN folliculitis_NN is_VBZ a_DT chronic_JJ disease_NN characterized_VBN by_IN pruritic_JJ follicular_JJ papules_NNS and_CC pustules_NNS located_VBN primarily_RB on_IN the_DT upper_JJ trunk_NN ,_, neck_NN ,_, and_CC upper_JJ arms_NNS ._SENT Under_IN the_DT influence_NN of_IN predisposing_VBG factors_NNS ,_, Malassezia_NP folliculitis_NN may_MD be_VB explained_VBN by_IN an_DT extensive_JJ growth_NN of_IN Malassezia_NP in_IN the_DT hair_NN follicle_NN ._SENT The_DT inflammation_NN may_MD be_VB due_JJ both_CC to_TO products_NNS of_IN the_DT yeast_NN and_CC free_JJ fatty_JJ acids_NNS produced_VBN as_IN a_DT result_NN of_IN the_DT lipase_NN activity_NN of_IN the_DT yeast_NN ._SENT The_DT diagnosis_NN is_VBZ based_VBN on_IN a_DT typical_JJ clinical_JJ picture_NN of_IN itchy_JJ papules_NNS and_CC pustules_NNS as_IN the_DT predominant_JJ symptoms_NNS ,_, direct_JJ microscopy_NN ,_, and_CC the_DT effect_NN of_IN antimycotic_JJ treatment_NN ._SENT The_DT effect_NN of_IN antimycotic_JJ treatment_NN is_VBZ often_RB dramatic_JJ ._SENT Most_JJS cases_NNS responds_VBZ well_RB to_TO topical_JJ treatment_NN ,_, but_CC systemic_JJ treatment_NN with_IN e.g._FW itraconazole_NN or_CC fluconazole_NN has_VBZ been_VBN used_VBN in_IN difficult_JJ cases_NNS ._SENT Lesions_NNS and_CC itching_VBG recur_VB in_IN most_JJS patients_NNS if_IN treatment_NN is_VBZ not_RB maintained_VBN intermittently_RB ._SENT Therefore_RB ,_, a_DT prophylactic_JJ treatment_NN schedule_NN ,_, such_JJ as_IN topical_JJ treatment_NN once_RB or_CC twice_RB a_DT week_NN ,_, is_VBZ recommended_VBN ._SENT Seborrheic_JJ dermatitis_NN is_VBZ characterized_VBN by_IN red_JJ scaly_JJ lesions_NNS located_VBN predominantly_RB on_IN the_DT scalp_NN ,_, face_NN ,_, and_CC upper_JJ trunk_NN ._SENT There_EX are_VBP now_RB many_JJ studies_NNS indicating_VBG that_IN the_DT Malassezia_NP yeasts_NNS play_VBP an_DT important_JJ role_NN in_IN seborrheic_JJ dermatitis_NN ._SENT Many_JJ of_IN these_DT are_VBP treatment_NN studies_NNS which_WDT describe_VBP the_DT effectiveness_NN of_IN antimycotics_NNS ,_, paralleled_VBN by_IN a_DT reduction_NN in_IN number_NN of_IN the_DT Malassezia_NP yeasts_NNS ,_, whereas_IN recolonization_NN leads_VBZ to_TO a_DT recurrence_NN of_IN seborrheic_JJ dermatitis_NN ._SENT The_DT increased_VBN incidence_NN of_IN seborrheic_JJ dermatitis_NN in_IN patients_NNS with_IN immunosuppressive_JJ disorders_NNS suggests_VBZ that_IN the_DT relationship_NN between_IN Malassezia_NP and_CC the_DT immune_JJ system_NN is_VBZ important_JJ ,_, but_CC the_DT exact_JJ mechanism_NN involved_VBN is_VBZ still_RB unknown_JJ ._SENT Studies_NNS designed_VBN to_TO investigate_VB this_DT mechanism_NN in_IN patients_NNS with_IN seborrheic_JJ dermatitis_NN fall_NN into_IN four_CD areas_NNS :_: the_DT humoral_JJ response_NN to_TO Malassezia_NP ,_, lymphocyte_NN transformation_NN response_NN to_TO Malassezia_NP extract_NN ,_, T_NN helper_NN (CD4)/T_NN suppressor_NN (_( CD8_NP )_) cell_NN ratios_NNS ,_, and_CC cytokine_NN responses_NNS ._SENT However_RB ,_, studies_NNS in_IN all_DT of_IN these_DT areas_NNS have_VBP given_VBN inconsistent_JJ results_NNS ,_, and_CC the_DT local_JJ reaction_NN in_IN the_DT skin_NN may_MD give_VB a_DT better_JJR answer_NN ._SENT In_IN a_DT recent_JJ study_NN ,_, the_DT number_NN and_CC type_NN of_IN inflammatory_JJ cells_NNS and_CC mediators_NNS from_IN lesional_JJ and_CC healthy_JJ skin_NN in_IN patients_NNS with_IN seborrheic_JJ dermatitis_NN were_VBD been_VBN studied_VBN ._SENT Staining_VBG was_VBD often_RB more_RBR intense_JJ when_WRB Malassezia_NP yeasts_NNS cells_NNS were_VBD present_JJ ._SENT An_DT increase_NN in_IN NK-_NP and_CC CD16-positive_JJ cells_NNS in_IN combination_NN with_IN complement_NN activation_NN indicates_VBZ that_IN an_DT irritant_JJ or_CC nonimmunogenic_JJ stimulation_NN of_IN the_DT immune_JJ system_NN is_VBZ important_JJ ._SENT With_IN the_DT interleukins_NNS ,_, an_DT increase_NN in_IN the_DT production_NN of_IN inflammatory_JJ interleukins_NNS and_CC an_DT increase_NN in_IN the_DT regulatory_JJ interleukins_NNS for_IN both_DT Th1_NP and_CC Th2_NP cells_NNS were_VBD seen_VBN ._SENT The_DT immune_JJ response_NN described_VBN for_IN cutaneous_JJ C._NP albicans_NP infections_NNS has_VBZ similarities_NNS to_TO the_DT skin_NN reactions_NNS found_VBN in_IN seborrheic_JJ dermatitis_NN ._SENT Distribution_NN of_IN the_DT Malassezia_NP yeasts_NNS ._SENT |_SYM Many_JJ reports_NNS clearly_RB indicate_VBP the_DT role_NN of_IN Malassezia_NP in_IN AD_NP ,_, especially_RB AD_NNS located_VBN to_TO the_DT head_NN and_CC neck_NN area_NN in_IN adults_NNS ._SENT The_DT Malassezia_NP yeasts_NNS have_VBP been_VBN cultured_VBN from_IN patients_NNS with_IN AD_NN with_IN the_DT same_JJ frequency_NN as_IN from_IN healthy_JJ individuals_NNS ._SENT In_IN one_CD study_NN of_IN children_NNS from_IN newborn_NN to_TO the_DT age_NN of_IN 20_CD years_NNS ,_, the_DT Malassezia_NP yeasts_NNS were_VBD isolated_VBN from_IN lesional_JJ and_CC nonlesional_JJ skin_NN ,_, from_IN the_DT same_JJ region_NN ,_, as_RB well_RB as_IN from_IN normal_JJ skin_NN of_IN the_DT forehead_NN of_IN patients_NNS with_IN AD_NP ._SENT Normal_JJ skin_NN on_IN the_DT forehead_NN in_IN age-_NN and_CC sex-matched_JJ individuals_NNS with_IN rhinoconjunctivitis_NN and/or_CC asthma_NN and_CC healthy_JJ volunteers_NNS served_VBN as_IN controls_NNS ._SENT Cultures_NNS did_VBD not_RB differ_VB significantly_RB among_IN the_DT three_CD groups_NNS or_CC between_IN lesional_JJ and_CC nonlesional_JJ skin_NN ._SENT There_EX was_VBD ,_, however_RB ,_, a_DT difference_NN between_IN the_DT age_NN groups_NNS ._SENT Cultures_NNS were_VBD positive_JJ in_IN 5_CD to_TO 15_CD %_NN of_IN children_NNS aged_VBN up_IN 10_CD years_NNS and_CC in_IN 65_CD to_TO 100_CD %_NN of_IN 11-_CD to_TO 20-year-old_JJ persons_NNS ._SENT In_IN a_DT study_NN of_IN adult_JJ patients_NNS with_IN AD_NNS involving_VBG the_DT scalp_NN and_CC neck_NN ,_, Malassezia_NP samples_NNS were_VBD taken_VBN from_IN lesional_JJ skin_NN of_IN the_DT forehead_NN and_CC cultured_VBN on_IN Leeming_NP and_CC Notman_NP agar_NN in_IN contact_NN plates_NNS ._SENT Culture_NN was_VBD positive_JJ in_IN 83_CD %_NN of_IN cases_NNS ._SENT These_DT two_CD studies_NNS were_VBD performed_VBN before_IN the_DT new_JJ taxonomy_NN for_IN the_DT Malassezia_NP yeasts_NNS was_VBD introduced_VBN ._SENT In_IN the_DT above-mentioned_JJ study_NN by_IN Nakabayashi_NP et_FW al._FW ,_, they_PP were_VBD able_JJ to_TO classify_VB the_DT Malassezia_NP yeasts_NNS ._SENT Samples_NNS were_VBD taken_VBN from_IN lesional_JJ and_CC nonlesional_JJ skin_NN from_IN the_DT scalp_NN ,_, face_NN ,_, and_CC trunk_NN ._SENT In_IN lesional_JJ skin_NN the_DT most_RBS commonly_RB isolated_VBN species_NNS was_VBD M._NP furfur_NN ,_, which_WDT was_VBD cultured_VBN in_IN 21_CD %_NN of_IN samples_NNS ._SENT M._NP globosa_NP was_VBD cultured_VBN in_IN 14_CD %_NN ,_, M._NP sympodialis_NNS was_VBD cultured_VBN in_IN 7_CD %_NN ,_, M._NP slooffiae_NNS was_VBD cultured_VBN in_IN 4_CD %_NN ,_, and_CC cultures_NNS were_VBD negative_JJ in_IN 46_CD %_NN ._SENT In_IN nonlesional_JJ skin_NN ,_, the_DT most_RBS commonly_RB isolated_VBN species_NNS was_VBD M._NP globosa_NP (_( 33_CD %_NN )_) ;_: M._NP furfur_NN was_VBD cultured_VBN in_IN 11_CD %_NN of_IN samples_NNS ;_: 22_CD %_NN were_VBD unknown_JJ species_NNS or_CC contaminated_JJ cultures_NNS ,_, and_CC 33_CD %_NN of_IN samples_NNS were_VBD culture_NN negative_JJ ._SENT Gupta_NP et_FW al._FW cultured_VBN the_DT Malassezia_NP yeasts_NNS semiquantitatively_RB ,_, using_VBG the_DT Leeming_NP and_CC Notman_NP culture_NN medium_NN in_IN contact_NN plates_NNS ,_, from_IN patients_NNS with_IN various_JJ skin_NN diseases_NNS and_CC healthy_JJ controls_NNS ._SENT In_IN patients_NNS with_IN AD_NP ,_, the_DT total_JJ number_NN of_IN isolated_JJ colonies_NNS was_VBD significantly_RB larger_JJR from_IN nonlesional_JJ skin_NN than_IN from_IN to_TO lesional_JJ skin_NN ._SENT The_DT number_NN of_IN colonies_NNS from_IN both_DT lesional_JJ and_CC nonlesional_JJ skin_NN was_VBD significantly_RB smaller_JJR than_IN the_DT number_NN of_IN colonies_NNS from_IN healthy_JJ individuals_NNS ,_, patients_NNS with_IN pityriasis_NN versicolor_JJ (_( both_DT lesional_JJ and_CC nonlesional_JJ skin_NN )_) ,_, and_CC nonlesional_JJ ,_, but_CC not_RB lesional_JJ ,_, skin_NN of_IN patients_NNS with_IN seborrheic_JJ dermatitis_NN ._SENT In_IN AD_NP there_EX were_VBD no_DT differences_NNS in_IN the_DT percentages_NNS of_IN the_DT various_JJ Malassezia_NP species_NNS isolated_VBN from_IN lesional_JJ and_CC nonlesional_JJ skin_NN ._SENT M._NP sympodialis_NP was_VBD the_DT most_RBS commonly_RB isolated_VBN species_NNS ,_, being_VBG cultured_VBN in_IN 51_CD %_NN of_IN the_DT patients_NNS ,_, M._NP globosa_NP was_VBD cultured_VBN in_IN 18_CD %_NN ,_, M._NP furfur_NN and_CC M._NP obtusa_NP were_VBD each_DT cultured_VBN in_IN 10_CD %_NN ,_, M._NP restrticta_NP was_VBD cultured_VBN in_IN 8_CD %_NN ,_, and_CC M._NP slooffiae_NNS was_VBD cultured_VBN in_IN 3_CD %_NN ._SENT The_DT majority_NN of_IN Malassezia_NP yeasts_NNS were_VBD cultured_VBN from_IN the_DT forehead_NN and_CC the_DT trunk_NN ._SENT In_IN an_DT English_JJ abstract_NN from_IN a_DT paper_NN otherwise_RB written_VBN in_IN Russian_NP ,_, Arzumanian_NP stated_VBD that_IN M._NP sympodialis_NP was_VBD the_DT most_RBS commonly_RB isolated_VBN species_NNS isolated_VBN from_IN both_DT patients_NNS with_IN AD_JJ and_CC healthy_JJ individuals_NNS ._SENT In_IN a_DT recently_RB completed_VBN multicenter_NN study_NN in_IN Sweden_NP ,_, involving_VBG the_DT Departments_NPS of_IN Dermatology_NP in_IN Gothenburg_NP ,_, Lund_NP ,_, and_CC Stockholm_NP and_CC the_DT Department_NP of_IN Clinical_NP Immunology_NP ,_, Karolinska_NP Hospital_NP ,_, Stockholm_NP ,_, we_PP cultured_VBD the_DT Malassezia_NP yeasts_NNS from_IN 125_CD patients_NNS with_IN AD_NP ,_, 16_CD with_IN seborrhec_NN dermatitis_NN ,_, and_CC 30_CD healthy_JJ controls_NNS ._SENT Cultures_NNS were_VBD performed_VBN using_VBG the_DT Leeming_NP and_CC Notman_NP agar_NN in_IN contact_NN plates_NNS from_IN normal-appearing_VBG skin_NN of_IN the_DT upper_JJ back_NN and_CC ,_, in_IN AD_NN and_CC seborrheic_JJ dermatitis_NN patients_NNS ,_, also_RB from_IN lesional_JJ skin_NN ._SENT Cultures_NNS were_VBD positive_JJ in_IN 56_CD %_NN of_IN patients_NNS (_( 70_CD of_IN 125_CD )_) with_IN AD_NP ,_, 88_CD %_NN of_IN patients_NNS with_IN seborrheic_JJ dermatitis_NN ,_, and_CC 83_CD %_NN of_IN healthy_JJ controls_NNS ._SENT In_IN patients_NNS with_IN AD_NP ,_, M._NP sympodialis_NNS was_VBD cultured_VBN in_IN 40_CD %_NN ,_, M._NP obtusa_NP was_VBD cultured_VBN in_IN 25_CD %_NN ,_, M._NP globosa_NP was_VBD cultured_VBN in_IN 23_CD %_NN ,_, M._NP slooffiae_NNS was_VBD cultured_VBN in_IN 6_CD %_NN ,_, M._NP furfur_NN was_VBD cultured_VBN in_IN 4_CD %_NN ,_, and_CC M._NP restricta_NP was_VBD cultured_VBN in_IN 2_CD %_NN ._SENT The_DT same_JJ frequency_NN of_IN the_DT Malassezia_NP yeasts_NNS was_VBD seen_VBN in_IN healthy_JJ controls_NNS ._SENT However_RB ,_, in_IN patients_NNS with_IN seborrheic_JJ dermatitis_NN ,_, M._NP obtusa_NP was_VBD cultured_VBN in_IN 30_CD %_NN and_CC M._NP sympodialis_NNS was_VBD cultured_VBN in_IN 30_CD %_NN ._SENT A_DT positive_JJ skin_NN prick_NN test_NN (_( SPT_NP )_) was_VBD first_RB reported_VBN in_IN 1958_CD among_IN a_DT group_NN of_IN AD_JJ patients_NNS ._SENT In_IN 1983_CD ,_, Clemmensen_NP and_CC Hjorth_NP described_VBD a_DT positive_JJ effect_NN of_IN oral_JJ ketoconazole_NN in_IN the_DT treatment_NN of_IN adult_JJ patients_NNS with_IN AD_NNS localized_VBN to_TO the_DT head_NN and_CC neck_NN area_NN and_CC with_IN positive_JJ SPTs_NNS to_TO Malassezia_NP ._SENT In_IN 1985_CD ,_, Waerstad_NP and_CC Hjorth_NP investigated_VBD 741_CD patients_NNS with_IN AD_NN and_CC found_VBD a_DT positive_JJ Malassezia_NP SPT_NN only_RB in_IN patients_NNS with_IN active_JJ eczema_NN and_CC most_RBS frequently_RB in_IN patients_NNS with_IN head_NN and_CC neck_NN dermatitis_NN (_( 28_CD %_NN )_) ._SENT Patients_NNS with_IN other_JJ atopic_JJ manifestations_NNS such_JJ as_IN rhinitis_NN or_CC asthma_NN but_CC without_IN AD_NP were_VBD negative_JJ in_IN SPT_NP to_TO Malassezia_NP ._SENT Kieffer_NP et_FW al._FW ,_, in_IN collaboration_NN with_IN our_PP$ group_NN in_IN Gothenburg_NP ,_, reported_VBD a_DT positive_JJ SPT_NN to_TO Malassezia_NP in_IN 79_CD %_NN of_IN adult_JJ patients_NNS with_IN AD_NNS localized_VBN to_TO the_DT head_NN and_CC neck_NN area_NN ._SENT The_DT SPT_NN was_VBD positive_JJ in_IN 45_CD %_NN of_IN patients_NNS with_IN AD_NN but_CC without_IN the_DT head_NN and_CC neck_NN distribution_NN ,_, and_CC patients_NNS with_IN seborrhoeic_JJ dermatitis_NN were_VBD negative_JJ ._SENT These_DT percentages_NNS are_VBP much_RB higher_JJR than_IN those_DT obtained_VBN by_IN Waersted_NP and_CC Hjorth_NP ._SENT However_RB ,_, several_JJ children_NNS were_VBD included_VBN in_IN the_DT report_NN by_IN Waerstad_NP and_CC Hjorth_NP ._SENT The_DT Malassezia_NP extract_NN used_VBN in_IN this_DT and_CC the_DT two_CD earlier_JJR studies_NNS is_VBZ a_DT protein_NN extract_NN prepared_VBN by_IN ALK_NP Laboratories_NPS ,_, Copenhagen_NP ,_, Denmark_NP ._SENT The_DT same_JJ extract_NN has_VBZ also_RB been_VBN used_VBN for_IN a_DT histamine_NN release_NN assay_NN (_( Lucotest-HR_NP ;_: Lundbeck_NP Diagnostics_NP ,_, Copenhagen_NP ,_, Denmark_NP )_) measuring_VBG the_DT release_NN of_IN histamine_NN from_IN basophils_NNS after_IN stimulation_NN with_IN the_DT antigen_NN ._SENT The_DT results_NNS of_IN histamine_NN release_NN after_IN stimulation_NN with_IN Malassezia_NP extract_NN paralleled_VBD the_DT results_NNS obtained_VBN with_IN the_DT SPT_NN ._SENT Rokugo_NP et_FW al._FW found_VBD that_IN the_DT results_NNS of_IN the_DT SPT_NNS vary_VBP according_VBG to_TO the_DT age_NN of_IN the_DT patients_NNS ._SENT Among_IN AD_JJ patients_NNS younger_JJR than_IN 10_CD years_NNS ,_, 39_CD %_NN were_VBD positive_JJ in_IN SPT_NP ,_, while_IN 64_CD %_NN of_IN patients_NNS older_JJR than_IN 10_CD years_NNS were_VBD positive_JJ ._SENT Wessels_NP et_FW al._FW found_VBN positive_JJ SPTs_NNS to_TO Malassezia_NP in_IN 84_CD %_NN of_IN adult_JJ patients_NNS with_IN AD_NN ._SENT In_IN a_DT study_NN by_IN Broberg_NP et_FW al._FW ,_, children_NNS with_IN AD_NP ,_, rhinitis_NN and/or_CC asthma_NN without_IN AD_NN ,_, and_CC healthy_JJ controls_NNS were_VBD investigated_VBN ._SENT A_DT total_NN of_IN 60_CD children_NNS in_IN each_DT category_NN were_VBD included_VBN ,_, and_CC the_DT children_NNS were_VBD divided_VBN into_IN four_CD groups_NNS :_: 0_CD to_TO 5_CD years_NNS ,_, 6_CD to_TO 10_CD years_NNS ,_, 11_CD to_TO 15_CD years_NNS ,_, and_CC 16_CD to_TO 21_CD years_NNS ,_, with_IN 15_CD in_IN each_DT group_NN ._SENT SPTs_NNS to_TO Malassezia_NP were_VBD positive_JJ in_IN 23_CD %_NN of_IN patients_NNS with_IN AD_NP ,_, 0_CD %_NN of_IN patients_NNS with_IN rhinitis_NN and/or_CC asthma_NN ,_, and_CC 8_CD %_NN of_IN healthy_JJ controls_NNS (_( three_CD subjects_NNS )_) ._SENT Among_IN the_DT patients_NNS with_IN AD_NP ,_, 1_CD of_IN 15_CD patients_NNS in_IN the_DT age_NN group_NN from_IN 0_CD to_TO 5_CD years_NNS was_VBD SPT_JJ positive_NN compared_VBN to_TO 6_CD of_IN 15_CD (_( 40_CD %_NN )_) in_IN the_DT age_NN group_NN from_IN 16_CD to_TO 21_CD years_NNS ._SENT Kim_NP et_FW al._FW have_VBP performed_VBN an_DT SPT_NN with_IN an_DT M._NP furfur_NN extract_NN in_IN 80_CD young_JJ adult_NN patients_NNS with_IN the_DT head_NN and_CC neck_NN distribution_NN of_IN AD_NNS and_CC compared_VBN the_DT results_NNS to_TO those_DT obtained_VBN for_IN controls_NNS without_IN AD_NP ._SENT A_DT total_NN of_IN 45_CD %_NN showed_VBD positive_JJ SPT_NN responses_NNS ,_, and_CC the_DT severity_NN score_NN of_IN the_DT head_NN and_CC neck_NN lesions_NNS in_IN the_DT M._NP furfur_NN SPT-positive_NP group_NN was_VBD significantly_RB higher_JJR than_IN in_IN the_DT M._NP furfur-negative_JJ group_NN ._SENT In_IN another_DT study_NN ,_, Devos_NP and_CC van_NP der_NP Valk_NP studied_VBD patients_NNS with_IN AD_NN ,_, with_IN and_CC without_IN the_DT head_NN and_CC neck_NN distribution_NN ,_, using_VBG SPT_NN with_IN a_DT Malassezia_NP extract_NN and_CC other_JJ procedures_NNS ._SENT In_IN a_DT total_NN of_IN 92_CD patients_NNS with_IN AD_NN (_( the_DT majority_NN were_VBD young_JJ adults_NNS )_) ,_, the_DT SPT_NN was_VBD positive_JJ in_IN 40_CD %_NN ._SENT However_RB ,_, only_RB 6_CD %_NN of_IN the_DT patients_NNS with_IN the_DT head_NN and_CC neck_NN distribution_NN of_IN AD_NP were_VBD positive_JJ ._SENT This_DT is_VBZ contradictory_JJ to_TO all_DT earlier_JJR studies_NNS ,_, in_IN which_WDT patients_NNS with_IN the_DT head_NN and_CC neck_NN distribution_NN of_IN AD_NP showed_VBD the_DT largest_JJS number_NN of_IN positive_JJ SPTs_NNS to_TO Malassezia_NP ._SENT In_IN the_DT above-mentioned_JJ Swedish_JJ multicenter_NN study_NN ,_, we_PP also_RB performed_VBD SPT_NN with_IN extracts_VBZ of_IN Malassezia_NP ,_, the_DT recombinant_JJ allergens_NNS Mal_NP f_SYM 1_CD ,_, Mal_JJ f_NN 5_CD ,_, Mal_JJ f_NN 6_CD ,_, and_CC a_DT mix_NN of_IN these_DT recombinant_JJ allergens_NNS in_IN patients_NNS with_IN AD_NNS ,_, patients_NNS with_IN seborrheic_JJ dermatitis_NN ,_, and_CC healthy_JJ controls_NNS ;_: 74_CD %_NN of_IN the_DT AD_JJ patients_NNS had_VBD the_DT head_NN and_CC neck_NN distribution_NN ._SENT We_PP found_VBD that_IN 57_CD %_NN of_IN the_DT AD_JJ patients_NNS were_VBD positive_JJ to_TO the_DT extract_NN or_CC recombinant_JJ allergens_NNS ;_: 52_CD %_NN were_VBD positive_JJ to_TO the_DT Malassezia_NP extract_NN ._SENT However_RB ,_, 56_CD %_NN of_IN patients_NNS with_IN the_DT head_NN and_CC neck_NN distribution_NN of_IN AD_NP were_VBD positive_JJ to_TO the_DT extract_NN compared_VBN to_TO only_RB 36_CD %_NN of_IN the_DT patien_NP 